Streetbeat News

Assets

BTCUSD

Peter Schiff, a well-known gold advocate, criticized Bitcoin, claiming it lacks intrinsic value and is destined to fail. He argues that Bitcoin's ease of transfer undermines its value and contrasts it with gold's physical properties. Schiff remains bullish on gold mining stocks and suggests Bitcoin investors consider this sector.

Portfolio Pulse from Khyathi Dalal

September 11, 2024 | 4:42 pm

BCTX

BriaCell Therapeutics announced an $8.5 million best-efforts offering of 12.325 million common shares at $0.69 per share. The proceeds will be used for working capital, corporate purposes, and business advancement. The offering is expected to close on September 12, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 4:14 pm

DIS

Deep-pocketed investors are showing a bullish sentiment towards Walt Disney (NYSE:DIS) as revealed by Benzinga's options scanner, which highlighted 14 extraordinary options activities. The sentiment is divided with 57% bullish and 42% bearish, indicating potential significant price movements between $70 and $130. The current price of DIS is $86.88, down 1.73%.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 3:30 pm

DVDN

IVR

MORT

RKT

SRET

TREE

Mortgage rates have fallen to their lowest level since February 2023, encouraging refinancing. The average rate for 30-year fixed-rate mortgages decreased to 6.29%. Despite the drop, affordability challenges persist. Stocks like Invesco Mortgage Capital, Rocket Companies, and Lendingtree saw declines, while ETFs had mixed reactions.

Portfolio Pulse from Michael Juliano

September 11, 2024 | 3:30 pm

CMCSA

The article evaluates Comcast's performance against its competitors in the media industry, highlighting its high valuation ratios (P/E, P/B, P/S) compared to industry averages, but also its strong financial metrics like ROE, EBITDA, gross profit, and revenue growth. Comcast's debt-to-equity ratio is moderate among peers, indicating a balanced financial structure.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 3:00 pm

REGN

The article provides a comprehensive analysis of Regeneron Pharmaceuticals (NASDAQ:REGN) compared to its competitors in the Biotechnology industry. It highlights Regeneron's financial metrics, indicating potential undervaluation with low PE, PB, and PS ratios. However, the company shows lower ROE and revenue growth compared to industry averages, despite strong EBITDA and gross profit. Regeneron's lower debt-to-equity ratio suggests a strong financial position.

Portfolio Pulse from Benzinga Insights

September 11, 2024 | 3:00 pm

PCT

PureCycle Technologies shares rose following the announcement of a $90 million capital raise through transactions with Sylebra Capital Management and Samlyn Capital.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 2:38 pm

SPY

UNG

The latest data shows a significant build in US gasoline inventories, with an increase of 2.310 million barrels compared to the expected draw of 0.400 million barrels. This contrasts with the previous build of 0.848 million barrels.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 2:30 pm

USO

The EIA reported a larger-than-expected build in distillate stocks, with an increase of 2.308 million barrels compared to the estimated 0.300 million. This follows a previous draw of 0.371 million barrels.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 2:30 pm

SPY

USO

The latest report on USA crude oil inventories shows a build of 0.833 million barrels, which is slightly below the expected build of 0.900 million barrels. This follows a significant draw of 6.873 million barrels in the previous report.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 2:30 pm